I think investors will not only hold NOW given the rise of SP that will eventuate in anticipation of the viable SS, but also hold post-SS given the likelihood of a JV/Buyout, especially the interest that will be received during BB’s presentations in the US on the 24th of October, coupled with the interest gained when Core Consultants and USQ Capital showcases the SS in London in November.
Adding more to my holdings at these ridiculously cheap prices.IMHO, with doing all the calculations + the management on board+ being one of the worlds largest cobalt resources outside the DRC, I think only smart investors will truly realise the potential growth of this unique Cobalt stock.
Hence, I conclude with my predictions
Pre-SS: 15-18c
Post-SS: 27-35c
Mark my words, this company will be bought out.
Where else will companies find the needed Cobalt?
Il leave you guys to imagine/predict the SP when the buyout happens.
All comments made IMO bla bla bla
- Forums
- ASX - By Stock
- CLA
- Pre Scoping Study and General Thoughts
Pre Scoping Study and General Thoughts, page-12
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLA (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.56M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.3¢ | $95.25K | 6.822M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2000119 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2794159 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2000119 | 0.013 |
7 | 3975835 | 0.012 |
10 | 3483211 | 0.011 |
9 | 1948999 | 0.010 |
5 | 3281630 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 2794159 | 4 |
0.015 | 2400791 | 7 |
0.016 | 7710548 | 12 |
0.017 | 1036932 | 4 |
0.018 | 2980756 | 7 |
Last trade - 14.46pm 15/07/2024 (20 minute delay) ? |
Featured News
CLA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online